Vaccine Manufacturing & Regulatory Advances: Riding COVID's Coattails
-
Vaccine Manufacturing & Regulatory Advances: Riding COVID's Coattails
5/19/2021
Accelerated by the COVID-19 pandemic, nucleic acid, viral vector-based, inactivated, and other vaccine tech targeting a host of disease states are experiencing a rapid resurgence among biopharmas large and small. Learn how next-generation vaccine manufacturers are changing the egg yolk manufacturing paradigm and seizing an unprecedented regulatory momentum.
This website uses cookies to ensure you get the best experience on our website. Learn more